Micropulse laser for diabetic eye swelling
Part of Cancer, Eyes & vision clinical trials.
This trial tests a gentle laser treatment (micropulse laser) to reduce swelling in the center of the retina caused by diabetes. The goal is to improve or protect your vision without the need for injections or stronger laser.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 18.
- You must have diabetic retinopathy with swelling in the central part of your vision (macular edema) that is not too severe.
- Your central vision must be within a certain range of clearness (best corrected visual acuity between 6/18 and 6/60).
- You cannot have had laser treatment, anti-VEGF injections, or vitrectomy in the affected eye before.
- You cannot have significant lack of blood flow in the retina (macular ischemia) or other serious eye diseases like glaucoma or age-related macular degeneration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a more frequent dosing of an eye injection called pegaptanib (Macugen) to see if it can quickly reduce swelling in the retina caused by diabetes and improve vision. It is for people with diabetic macular edema who have some vision loss.
This Phase 1 trial tests MS-553 to see how it works and how safely it can be given to people with diabetic retinopathy causing central macular swelling (macular edema). You may be considered if your vision and eye scan results match, and if you can follow frequent study visits.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This study tests whether a medication called dapagliflozin, which is usually used for diabetes and heart failure, can help reduce swelling in the retina (diabetic macular edema) and improve vision. It is for people with type 2 diabetes who are already taking insulin and metformin.
This trial tests whether a single steroid injection around the back of the eye can improve vision in people with diabetic macular edema (swelling in the center of the retina that blurs vision). It is for people who have not yet had any other eye treatments for this condition.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
Hear when a new Diabetic Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.